SV Health Investors’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

SV Health Investors’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-888,132	Closed	-$7.97M	–	7
2016 Q3	$7.97M	Hold	888,132	–	–	6.12%	5
2016 Q2	$4.77M	Hold	888,132	–	–	4.82%	5
2016 Q1	$4.08M	Hold	888,132	–	–	3.05%	5
2015 Q4	$4.62M	Buy	+888,132	New	+$5.15M	3.71%	5

SV Health Investors's RPTP Position: Q4 2016 in Review

SV Health Investors sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 888,132 shares — an estimated $7.97M sold.

SV Health Investors first reported a position in RPTP in Q4 2015 and held it in 4 quarters. The position peaked at $7.97M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

SV Health Investors reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
SV Health Investors sold 888,132 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $7.97M.
SV Health Investors first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2015 and held it in 4 quarters.
SV Health Investors's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $7.97M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on SV Health Investors's 13F filing for Q4 2016, filed 7 Feb 2017.